Company Directory / medical devices
PrivateFor profitmedical devicesSan Jose, United States
NeuSpera Medical
NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.
- Founded
- 2013 13 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $135M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
13 years old.
Reach
Website ranked #6,694,088 in the world for traffic, about 1k visits a month.
What it does
Machinery ManufacturingMedical DeviceProduct Design
Funding, as listed
$135M currency not stated
- Rounds6
- LatestSeries d, Jul 2024
- Investors9, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about NeuSpera Medical, field by field. Contact details are held but never shown.
The company
- Name
- NeuSpera Medical
- Type
- For profit
- Status
- Private
- Founded
- 2013
- Founders
- Alexander Yeh
- Industry
- medical devices
- Categories
- Machinery Manufacturing, Medical Device, Product Design
Where
- City
- San Jose
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #6,694,088
- Monthly web visits
- 1,045
- Apps
- 2
Funding, as listed
- Total
- 134,888,888 (currency not stated)
- Rounds
- 6
- Latest round
- Series d
- Latest round date
- Jul 2024
- Investors
- 9
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
NeuSpera Medical may be growing as it has successfully completed the enrolment of patients and implant procedures for the SANS-UUI pivotal clinical study of its Neuspera System. This milestone indicates progress in the company's clinical development and could potentially lead to the commercialization of their product. The completion of patient enrolment in a pivotal study is a critical step for medical device companies, as it allows them to gather the necessary data for regulatory approvals and market entry. The advancement of the Neuspera System through clinical trials demonstrates NeuSpera Medical's commitment to innovation and its ability to execute on its clinical development plans.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
medical devices in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.